Precision treatment in advanced hepatocellular carcinoma

Area of Science:

• Oncology
• Precision Medicine
• Hepatocellular Carcinoma Research

Background:

• Significant advances in systemic treatment for advanced hepatocellular carcinoma (HCC) have occurred.
• Despite progress, many HCC patients show resistance to current therapies, limiting treatment success.
• Precision treatment, personalizing care based on individual molecular profiles, is emerging but nascent in HCC.

Purpose of the Study:

• To review key aspects of precision treatment in hepatocellular carcinoma (HCC).
• To discuss therapeutic biomarkers, molecular classifications, and tumor microenvironment heterogeneity in HCC.
• To propose future directions for advancing precision medicine in HCC.

Main Methods:

• Review of current literature on precision treatment strategies in advanced HCC.
• Analysis of therapeutic biomarkers and molecular classifications relevant to HCC.
• Examination of tumor microenvironment heterogeneity and its impact on treatment response.

Main Results:

• Precision treatment holds promise for maximizing efficacy and minimizing side effects in HCC.
• Understanding molecular characteristics and tumor heterogeneity is crucial for personalized HCC therapy.
• Current application of precision medicine in HCC is still in early stages.

Conclusions:

• Precision medicine represents a paradigm shift for treating advanced HCC.
• Further research into biomarkers, molecular subtypes, and microenvironment is essential.
• Personalized therapeutic approaches, including functional assays, will drive future HCC advancements.